• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多发性骨髓瘤完全接种疫苗患者 SARS-CoV-2 突破感染和住院的风险。

Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma.

机构信息

Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio.

Center for Science, Health, and Society, School of Medicine, Case Western Reserve University, Cleveland, Ohio.

出版信息

JAMA Netw Open. 2021 Nov 1;4(11):e2137575. doi: 10.1001/jamanetworkopen.2021.37575.

DOI:10.1001/jamanetworkopen.2021.37575
PMID:34812850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8611483/
Abstract

This cohort study assesses the risk of breakthrough SARS-CoV-2 infection and hospitalization among fully vaccinated patients with multiple myeloma.

摘要

本队列研究评估了多发性骨髓瘤的完全接种疫苗患者发生突破性 SARS-CoV-2 感染和住院的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ad/8611483/e4740a98d32f/jamanetwopen-e2137575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ad/8611483/e4740a98d32f/jamanetwopen-e2137575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ad/8611483/e4740a98d32f/jamanetwopen-e2137575-g001.jpg

相似文献

1
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma.多发性骨髓瘤完全接种疫苗患者 SARS-CoV-2 突破感染和住院的风险。
JAMA Netw Open. 2021 Nov 1;4(11):e2137575. doi: 10.1001/jamanetworkopen.2021.37575.
2
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
3
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.2021 年 1 月至 9 月，九个州感染诱导或 mRNA 疫苗诱导的 SARS-CoV-2 免疫的具有 COVID-19 样疾病住院成人的实验室确诊 COVID-19。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1539-1544. doi: 10.15585/mmwr.mm7044e1.
4
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021.按疫苗接种状况监测2021年4月4日至7月17日美国13个司法管辖区的新冠病毒疾病病例、住院情况和死亡情况
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290. doi: 10.15585/mmwr.mm7037e1.
5
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.接种疫苗的医护人员中突破性 SARS-CoV-2 感染的危险因素。
PLoS One. 2021 Oct 15;16(10):e0258820. doi: 10.1371/journal.pone.0258820. eCollection 2021.
6
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.基于反事实解释的处理后平均处理效应（SATT）分析表明，BMT 和 SARS-CoV-2 疫苗接种是与多发性骨髓瘤患者 COVID-19 严重程度和生存相关的保护性风险因素。
Blood Cancer J. 2023 Dec 7;13(1):180. doi: 10.1038/s41408-023-00901-y.
7
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.疫苗接种后，熟练护理机构居民和工作人员中的 SARS-CoV-2 感染 - 伊利诺伊州芝加哥，2020 年 12 月至 2021 年 3 月。
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):632-638. doi: 10.15585/mmwr.mm7017e1.
8
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.接种疫苗后出现突破性SARS-CoV-2感染患者的结局
Int J Infect Dis. 2021 Sep;110:353-358. doi: 10.1016/j.ijid.2021.08.008. Epub 2021 Aug 8.
9
Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.新冠病毒疫苗在 B.1.617.2（德尔塔）变异株流行前后预防一线工作人员感染 SARS-CoV-2 的效果-2020 年 12 月至 2021 年 8 月美国 8 个地点。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1167-1169. doi: 10.15585/mmwr.mm7034e4.
10
SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.在多民族的英国医疗保健工作者中，对 SARS-CoV-2 疫苗的接种情况：一项横断面研究。
PLoS Med. 2021 Nov 5;18(11):e1003823. doi: 10.1371/journal.pmed.1003823. eCollection 2021 Nov.

引用本文的文献

1
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapies.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种揭示了不同淋巴瘤亚型和治疗方法中独特的免疫功能障碍。
Res Sq. 2025 Jul 4:rs.3.rs-7016519. doi: 10.21203/rs.3.rs-7016519/v1.
2
Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort Analysis.炎症性肠病患者在感染严重急性呼吸综合征冠状病毒2后发生呼吸道合胞病毒感染的风险增加：一项倾向匹配队列分析。
Clin Transl Gastroenterol. 2025 May 1;16(5):e00840. doi: 10.14309/ctg.0000000000000840.
3

本文引用的文献

1
Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.血液系统恶性肿瘤患者接种mRNA抗SARS-CoV-2疫苗后血清转化率低。
Leuk Lymphoma. 2021 Dec;62(13):3308-3310. doi: 10.1080/10428194.2021.1957877. Epub 2021 Jul 26.
2
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma.多发性骨髓瘤患者对两剂新冠病毒RNA疫苗的严重急性呼吸综合征冠状病毒2刺突抗体反应高度可变。
Cancer Cell. 2021 Aug 9;39(8):1028-1030. doi: 10.1016/j.ccell.2021.06.014. Epub 2021 Jun 29.
3
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
Association of adverse cardiovascular events with gabapentin and pregabalin among patients with fibromyalgia.
纤维肌痛患者中加巴喷丁和普瑞巴林与不良心血管事件的关联。
PLoS One. 2024 Jul 26;19(7):e0307515. doi: 10.1371/journal.pone.0307515. eCollection 2024.
4
Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study.初治2型糖尿病患者中使用非胰岛素类抗糖尿病药物与肺癌风险：一项全国性回顾性队列研究
Cancers (Basel). 2024 Jun 28;16(13):2377. doi: 10.3390/cancers16132377.
5
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.胰高血糖素样肽 1 受体激动剂与 2 型糖尿病患者的 13 种肥胖相关癌症。
JAMA Netw Open. 2024 Jul 1;7(7):e2421305. doi: 10.1001/jamanetworkopen.2024.21305.
6
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population.司美格鲁肽与真实人群中酒精使用障碍的发生率和复发率的关联。
Nat Commun. 2024 May 28;15(1):4548. doi: 10.1038/s41467-024-48780-6.
7
Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis.结直肠癌患者中出现SARS-CoV-2突破性感染的风险增加：一项基于人群的倾向匹配分析。
J Clin Med. 2024 Apr 24;13(9):2495. doi: 10.3390/jcm13092495.
8
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.GLP-1 受体激动剂与 2 型糖尿病患者肝癌发病率和肝功能失代偿的相关性。
Gastroenterology. 2024 Sep;167(4):689-703. doi: 10.1053/j.gastro.2024.04.029. Epub 2024 Apr 29.
9
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study.在真实人群中，与大麻使用障碍的发病率和复发率降低相关的司美格鲁肽：一项回顾性队列研究。
Mol Psychiatry. 2024 Aug;29(8):2587-2598. doi: 10.1038/s41380-024-02498-5. Epub 2024 Mar 14.
10
Association of semaglutide with risk of suicidal ideation in a real-world cohort.在真实世界队列中，司美格鲁肽与自杀意念风险的关联。
Nat Med. 2024 Jan;30(1):168-176. doi: 10.1038/s41591-023-02672-2. Epub 2024 Jan 5.
美国癌症和 COVID-19 感染患者的风险、种族差异和结局分析。
JAMA Oncol. 2021 Feb 1;7(2):220-227. doi: 10.1001/jamaoncol.2020.6178.
4
When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.当血液系统恶性肿瘤在美国遭遇 COVID-19：感染、死亡和差异。
Blood Rev. 2021 May;47:100775. doi: 10.1016/j.blre.2020.100775. Epub 2020 Nov 9.
5
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.《流行病学观察性研究报告强化（STROBE）声明》：观察性研究报告指南
Bull World Health Organ. 2007 Nov;85(11):867-72. doi: 10.2471/blt.07.045120.